The objectives of this project are the identification of markers related to cancer therapy resistance in the blood of breast cancer patients and to study the genetic changes in cancer cells during this development of resistance. Whole genome amplified DNA from Circulating Tumor Cells (CTCs), selected during the course of systemic treatment from blood of metastatic breast cancer patients, will be exome sequenced . The patients selected for this study did not respond to therapy.
- Type: Other
- Archiver: EGA European Genome-Phenome Archive
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
|EGAD00001001425||Illumina HiSeq 2000||149|
|EGAD00001005020||Illumina HiSeq 2000||28|
Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Breast Cancer Res 21: 2019 101